Volume 5 Issue 3
Jul.  2014
Turn off MathJax
Article Contents
Xin FAN, Meng XIAO, Qi-wen YANG, Hong-tao DOU, Li-na GUO, He WANG, Ying YUAN, Peng WANG, Ying ZHAO, Qi ZHANG, Yong-hong XIAO, Ying-chun XU. Antimicrobial Susceptibility of Multi-drug Resistant Acinetobacter Baumannii and Pseudomonas Aeruginosa Isolates from 27 Hospitals in China[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(3): 253-258. doi: 10.3969/j.issn.1674-9081.2014.03.002
Citation: Xin FAN, Meng XIAO, Qi-wen YANG, Hong-tao DOU, Li-na GUO, He WANG, Ying YUAN, Peng WANG, Ying ZHAO, Qi ZHANG, Yong-hong XIAO, Ying-chun XU. Antimicrobial Susceptibility of Multi-drug Resistant Acinetobacter Baumannii and Pseudomonas Aeruginosa Isolates from 27 Hospitals in China[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(3): 253-258. doi: 10.3969/j.issn.1674-9081.2014.03.002

Antimicrobial Susceptibility of Multi-drug Resistant Acinetobacter Baumannii and Pseudomonas Aeruginosa Isolates from 27 Hospitals in China

doi: 10.3969/j.issn.1674-9081.2014.03.002
More Information
  • Corresponding author: XU Ying-chun Tel: 010-69159766, E-mail:xycpumch@139.com
  • Received Date: 2014-04-29
  • Publish Date: 2014-07-30
  •   Objective  To investigate the antimicrobial susceptibilities of nosocomial multi-drug resistantAcinetobacter baumannii(MDR-AB) and multi-drug resistant Pseudomonas aeruginosa(MDR-PA) isolates.  Methods  MDR-AB and MDR-PA isolates were collected between August 2011 and July 2012 from 27 hospitals in China. All isolates were collected from high quality samples with definite infection diagnoses, whilst isolates from sputum and screen samples were strictly excluded. Minimum inhibitory concentrations (MICs) of 12 commonly used antimicrobial agents were tested by broth microdilution method in a microbiology laboratory. CLSI clinical breakpoints(CBPs) of pre- and post-revision were applied and compared in determination of MDR.  Results  A total of 664 MDR-AB and 268 MDR-PA isolates were collected. Pan-drug resistant (PDR) was detected in four Pseudomonas aeruginosa but not in Acinetobacter baumannii. The majority of isolates were collected from ICUs and surgical wards. Colistin and tigecycline were the most active agents against MDR-AB (96.8% and 72.6% susceptible, respectively), while no other drug exhibited activity of > 55% susceptible. Only 72.4% of MDR-PA isolates remained susceptible to colistin, but amikacin was more active to MDR-PA (64.2%) than MDR-AB (16.7%). By applying revised CBPs, the susceptibility of MDR-AB isolates to imipenem and meropenem decreased by 1.3% and 0.6%, respectively, whereas the susceptibility of MDR-PA to these two drugs decreased by 5.5% and 8.6%, respectively. The carbapenems susceptible rate of isolates collected from ICUs was lower than surgical and other wards. Isolates collected from different geographic regions showed varied resistant profiles.  Conclusions  Colistin and tigecycline are the most active drugs against MDR-AB, while colistin and amikacin have comparably good performance to MDR-PA.
  • loading
  • [1] 肖永红, 沈萍, 魏泽庆, 等. Mohnarin 2011年度全国细菌耐药监测[J].中华医院感染学杂志, 2012, 22:4946-4952. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyygrxzz201222008
    [2] Pitout JD. Extraintestinal pathogenic Escherichia coli:an update on antimicrobial resistance, laboratory diagnosis and treatment[J]. Expert Rev Anti Infect Ther, 2012, 10:1165-1176. doi:  10.1586/eri.12.110
    [3] Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:a systematic review of the literature[J]. J Hosp Infect, 2006, 64:7-15. doi:  10.1016/j.jhin.2006.04.015
    [4] Yang Q, Wang H, Chen M, et al. Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China:the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends(SMART)[J]. Int J Antimicrob Agents, 2010, 36:507-512. doi:  10.1016/j.ijantimicag.2010.09.001
    [5] Yang Q, Zhang H, Wang Y, et al. A ten-year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community-and hospital-associated intra-abdominal infections in China[J]. J Med Microbiol, 2013, 62(Pt 9):1343-1349. http://europepmc.org/abstract/med/23741022
    [6] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. M100-S22[S]. Wayne, PA: CLSI, 2012.
    [7] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-forth informational supplement. M100-S24[S]. Wayne, PA: CLSI, 2014.
    [8] Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition. M7-A9[S]. Wayne, PA: CLSI, 2012.
    [9] Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant(MDR)and pan-drug resistant(PDR)Acinetobacter baumannii and Pseudomonas aeruginosa[J]. J Med Microbiol, 2006, 55(Pt 12):1619-1629. http://www.ncbi.nlm.nih.gov/pubmed/17108263
    [10] Chan MC, Chiu SK, Hsueh PR, et al. Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections:a case-control study[J]. PLoS One, 2014, 9:e85973. doi:  10.1371/journal.pone.0085973
    [11] Xiao YH, Giske CG, Wei ZQ, et al. Epidemiology and characteristics of antimicrobial resistance in China[J]. Drug Resist Updat, 2011, 14:236-250. doi:  10.1016/j.drup.2011.07.001
    [12] Park SY, Choo JW, Kwon SH, et al. Risk factors for mortality in patients with Acinetobacter baumannii bacteremia[J]. Infect Chemother, 2013, 45:325-330. doi:  10.3947/ic.2013.45.3.325
    [13] The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0, 2014[EB/OL].[2014-04-29] http://www.eucast.org/clinical_breakpoints/
    [14] 张小江, 徐英春, 原英, 等.替加环素等14种抗菌药物对多重耐药菌的体外抗菌活性研究[J].中国感染与化疗杂志, 2009, 9:365-368. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgkgrhlzz200905010
    [15] 陈佰义, 何礼贤, 胡必杰, 等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志, 2012, 92:76-85. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201202002
    [16] Ji J, Wang J, Zhou Z, et al.Multilocus sequence typing reveals genetic diversity of carbapenem-or ceftazidime-nonsusceptible Pseudomonas aeruginosa in China[J].Antimicrob Agents Chemother, 2013, 57:5697-5700. doi:  10.1128/AAC.00970-13
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Article Metrics

    Article views (160) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return